Drug binding to blood proteins: Characteristics, roles and pathophysiological changes;Liaisons des médicaments aux protéines circulantes: Caractéristiques, rôles et modifications physio-pathologiques

Bulletin de l'Academie Nationale de Medecine

Volumn 190, Issue 4-5, 2006, Pages 935-946

  Tillement, Jean Paul ^a   Duché, Jean Claude ^b   Barré, Jérôme ^b  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b NONE

Author keywords

Albumins; Blood proteins; Lipoproteins; Orosomuco d; Protein binding

Indexed keywords

EID: 33751031225     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33276-5     Document Type: Review

References (21)

1. TILLEMENT J.P., HOUIN G., ZINI R., URIEN S., ALBENGRES E., BARRE J. et al. - The binding of drugs to blood plasma macromolecules : recent advances and therapeutic significance. Adv. Drug Res., 1984, 13, 59-94.
2. STRATTON C.W., RELLER L.B. - Serum dilution test for bactericidal activity I. Selection of a physiologic diluent. J. Infect. Dis., 1977, 136, 187-195.
3. BARRE J., URIEN S. - Distribution of drugs. In Clinical Pharmacology, Clinical Medicine Series Mc Graw - Hill, Edit., 2000, 37-43.
4. TILLEMENT J.P., TREMBLAY D. - Pharmacokinetic criteria for drug research and development. In Comprehensive Medicinal Chemistry ADMET/property-based approaches Elsevier, Edit., 2006, in press.
5. URIEN S., TILLEMENT J.P., BARRE J. - The significance of plasma-protein binding in drug research. In Pharmacokinetic optimization in drug research, Helvetica Chimica acta, Edit., 2000, 189-197.
6. YAP C.W., CHEN Y.Z. - Quantitative structure - pharmacokinetic relationships for drug distribution properties using general regression neural network. J. Pharm. Sci., 2005, 1, 153-168.
7. WUNDER A., MULLER-LADNER U., STELZE E.H., FUNK J., STEHLE G., PAP T. et al. - Albumin based delivery as novel therapeutic approach for rhumatoid arthritis. J. Immunol., 2003, 170, 4793-4801.
8. SHECHTER Y., MIRONCHIK M., RUBINRAUT S., SAUL A., TSUBERY H., FRIDKIN M. - Albumin-insulin conjugate releasing insulin slowly under physiological conditions : a new concept for long-acting insulin. Bioconjug. Chem., 2005, 16, 913-920.
9. WILLIAMS R.L. - Protein binding in hepatic disease : pharmacokinetic and clinical implications. In Protein binding and drug transport Schattauer Edit., 1985, 375-392.
10. Bow D.A., PERRY J.L., SIMON J.D., PROTCHARD J.B. - The impact of plasma protein binding on the renal transport of organic anions. J. Pharmacol. Exp. Ther., 2006, 316, 349-355.
11. BARRE J., ZINI R., TILLEMENT J.P. - The binding of erythromycin to proteins in the serum of humans during various infections. Infection, 1982, 10, S113-S115.
12. SHARGEL L., WU-PONG S., YA A. B. C. - Physiologic drug distribution and protein binding. In Applied Biopharmaceutics and Pharmacokinetics McGraw - Hill Edit., 2005, 251-297.
13. COSTIGAN M.G., YAQOOB M., LINDUP W.E. - Retention of an albumin-bound furan dicarboxylic acid in patients with renal failure after a kidney transplant. Nephrol. Dial. Transplant., 1996, 11, 809-807.
14. COLLIER R., LINDUP W.E. - Drug binding defect of uraemic plasma : inhibitory effect of furanoïd acids. Brit. J. Clin. Pharmacol., 1987, 23, 650P-651P.
15. SAKAI T., TAKADATE A., OTAGIRI M. - Characterisation of binding site of uremic toxins on human serum albumin. Biol. Pharm. Bull., 1995, 18, 1755-1761.
16. SARNATSKAYA V.V., LINDUP W.E., IVANOV A.I., YUSKO L.A., TJIA J., MASLENNY V.N. et al. - Extraction of uraemic toxins with activated carbon restores the functional properties of albumin. Nephron Physiol., 2003, 95, 10-18.
17. KRAGH-HANSEN U., BRENNAN S.O., GALLIANO M., SUGITA O. - Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations. Mol. Pharmacol., 1990, 37, 228-242.
18. BAUMANN P., EAP C.B. - Contribution of the variants of alpha-1 acid glycoprotein to its binding of drugs in Alpha 1 - acid glycoprotein : genetics, biochemistry, physiological functions and pharmacology. Prog. Clin. Biol. Res., 1989, 300, 379-397.
19. YUASA I., WEIDINGER S., UMETSU K., SUENAGA K., ISHIMOTO G., EAP C.B. et al. - Orosomucoid system : 17 additional orosomucoid variants and proposal for a new nomenclature. Vox Sang., 1993, 64, 47-55.
20. HERVÉ F., GOMAS E., DUCHE J.C., TILLEMENT J.P. - Evidence for difference in the binding of drugs to the two main genetic variants of human alpha- 1 acid glycoprotein. Brit. J. Clin. Pharmacol., 1993, 36, 241-249.
21. IVANOV A.I., KOROLENKO E.A., KOROLIK E.V., FIRSOV S.P., ZHBANKOV R.G., MARCHEWKA M.K., RATAJCZAK H. - Chronic liver and renal diseases differently affect structure of human serum albumin. Arch. Biochem. Biophys., 2002, 408, 69-77.